Quick Answer
QuidelOrtho Corp reported Diluted EPS of $16.69 per share (loss) for fiscal year 2025.
QuidelOrtho Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$16.69 | +45.4% |
| 2024 | -$30.54 | -20260.0% |
| 2023 | -$0.15 | -101.6% |
| 2022 | $9.56 | -41.8% |
| 2021 | $16.43 | -11.7% |
| 2020 | $18.60 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.78 | -3493.3% | -185.9% |
| June 30, 2025 | -$3.77 | -71.4% | -1884.2% |
| March 31, 2025 | -$0.19 | +99.3% | +36.7% |
| September 30, 2024 | -$0.30 | -57.9% | +86.4% |
| June 30, 2024 | -$2.20 | -175.0% | +91.4% |
| March 31, 2024 | -$25.50 | -3593.2% | -13321.1% |
| September 30, 2023 | -$0.19 | -167.9% | +76.2% |
| June 30, 2023 | -$0.80 | -322.2% | -209.6% |
- QuidelOrtho Corp showed an increase of +45.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, QuidelOrtho Corp’s diluted eps has declined by 189.7% (from $18.60 per share to $16.69 per share (loss)).
- The most recent figure is from QuidelOrtho Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: